Takada H, Tsuchiya K, *Demizu Y Helix-stabilized cell-penetrating peptides for delivery of antisense morpholino oligomers: Relationships among helicity, cellular uptake, and antisense activity Bioconjug. Chem. 38, 1311-1318 (2022).
Naganuma M, *Ohoka N, Tsuji G, Tsujimura H, Matsuno K, Inoue T, Naito M, *Demizu Y Development of chimeric molecules that degrade the estrogen receptor using decoy oligonucleotide ligands ACS Med. Chem. Lett. 13, 134-139 (2022).
Yamamoto J, Ito T, Yamaguchi Y, *Handa H. Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders. Chem. Soc. Rev. 51, 6234-6250 (2022).
Yokoo H, *Shibata N, Endo A, Ito T, Yanase Y, Murakami Y, Fujii K, Hamamura K, Saeki Y, *Naito M, *Aritake K, *Demizu Y Discovery of a highly potent and selective PROTAC targeting hematopoietic prostaglandin D synthase via in silico design J. Med. Chem. 64, 15868-15882 (2021)
Yokoo H, Ohoka N, Takyo M, Ito T, Tsuchiya K, Kurohara T, Fukuhara K, Inoue T, Naito M, *Demizu Y Peptide stapling improves the sustainability of a peptide-based chimeric molecule that induces targeted protein degradation Int. J. Mol. Sci. 22, 8772 (2021).
Shimizu N, Asatuma-Okumura T, Yamamoto J, Yamaguchi Y, *Handa H, *Ito T PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates Commun. Biol. 4, 1277 (2021).
Ito T, Yamaguchi Y, *Handa H. Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology Cell. Chem. Biol. 28, 987-999 (2021).
Okitsu K, Hattori T, Misawa T, Shoda T, Kurihara M, *Naito M, *Demizu Y Development of a small hybrid molecule that mediates degradation of His tag-fused proteins J. Med. Chem. 61, 576-582 (2018).
Matyskiela M E, *Lu G, Ito T (co-1st author), Pagarigan B, Lu C C, Miller K, Fang W, Wang N Y, Nguyen D, Houston J, Carmel G, Tran T, Riley M, Nosaka L, Lander G C, Gaidarova S, Xu S, Ruchelman A L, Handa H, Carmichael J, Daniel T O, Cathers B E, Lopez-Girona A, *Chamberlain P P. A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase Nature 535, 252-257 (2016).
Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, *Handa H. Identification of a primary target of thalidomide teratogenicity Science 327, 1345-1350 (2010).